From: A simulation analysis to characterize the dynamics of vaccinating behaviour on contact networks
Parameter | Meaning | Value | Reference |
---|---|---|---|
N | Population size | 5000 | assumption |
I _{0} | Initial number of individuals inoculated with smallpox | 10 | assumption |
ν | Mean node degree | 10 | assumption, Ref. [64] |
τ | Scaling constant for probability of infection from neighbours' neighbours | 0.2 | assumption |
β | Probability of node-to-node transmission | 0.02 day^{-1} | Ref. [43] |
β _{ perc } | Perceived probability of node-to-node transmission | 0.02 day^{-1} | Ref. [43] |
1/σ | Mean duration of latent period | 12 days | Ref. [65] |
V _{ σ } | Variance of latent period | 4 days^{2} | Ref. [65] |
1/γ | Mean duration of infectious period | 19 days | Ref. [65] |
V _{ γ } |
Variance of infectious period (original model) | 4 days^{2} | Ref. [65] |
V _{ ι } |
Variance of infectious period (extended model) | 4 days^{2} | Ref. [65] |
V _{ κ } | Variance of vaccine latent period | 4 days^{2} | Ref. [65] |
d _{ inf } | Probability of death due to infection | 0.3 | Ref. [66] |
d _{ vac } | Probability of death due to vaccine-related complications | 0.001 | assumption, Ref. [52] |
ϵ | Vaccine efficacy | 0.95 | Ref. [43] |
α | Payoff for individuals with continued susceptibility | 40 life-years | Ref. [67] |
L | Payoff for individuals with lifelong immunity | 40 life-years | Ref. [67] |